Business Description
Coya Therapeutics Inc
NAICS : 541714
SIC : 2834
Description
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.84 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 1.29 | |||||
| Debt-to-EBITDA | -1.18 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.45 | |||||
| 9-Day RSI | 72.41 | |||||
| 14-Day RSI | 71.24 | |||||
| 6-1 Month Momentum % | 8.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.54 | |||||
| Quick Ratio | 6.54 | |||||
| Cash Ratio | 6.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -2.93 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -240.13 | |||||
| ROA % | -100.92 | |||||
| ROIC % | -2930.1 | |||||
| ROC (Joel Greenblatt) % | -11004.01 | |||||
| ROCE % | -108.63 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 6.89 | |||||
| Price-to-Tangible-Book | 6.89 | |||||
| EV-to-EBIT | -7.78 | |||||
| EV-to-EBITDA | -7.8 | |||||
| EV-to-FCF | -7.92 | |||||
| Price-to-Net-Current-Asset-Value | 6.89 | |||||
| Price-to-Net-Cash | 7.64 | |||||
| Earnings Yield (Greenblatt) % | -12.85 | |||||
| FCF Yield % | -16.01 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:COYA
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Coya Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.251 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 71.24 | ||
| 14-Day ATR ($) | 0.576665 | ||
| 20-Day SMA ($) | 5.651635 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 3.21 - 8 | ||
| Shares Outstanding (Mil) | 10.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Coya Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Coya Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Coya Therapeutics Inc Frequently Asked Questions
What is Coya Therapeutics Inc(COYA)'s stock price today?
The current price of COYA is $6.96. The 52 week high of COYA is $8.00 and 52 week low is $3.21.
When is next earnings date of Coya Therapeutics Inc(COYA)?
The next earnings date of Coya Therapeutics Inc(COYA) is 2024-03-29 Est..
Does Coya Therapeutics Inc(COYA) pay dividends? If so, how much?
Coya Therapeutics Inc(COYA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers